As an effective target, EGFR locates on the cell surface and is overactivated in ≥50% NSCLC patients, which leads to uncontrolled activation of anti-apoptotic signal pathway and uncontrolled cell proliferation. Here, EGFR is linked to non-small cell lung carcinoma.